Influence of sotalol on the QT dispersion in patients with radiofrequency cathet er ablation
10.3321/j.issn:0258-879X.2001.02.020
- VernacularTitle:索他洛尔对射频消融患者QTd的影响
- Author:
Zhao-Hong LIU
1
;
De-Ning LIAO
;
Xue ZHAO
;
Jia-You ZHANG
Author Information
1. No.107 Hospital of PLA
- From:
Academic Journal of Second Military Medical University
2001;22(2):167-169
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To observe the influence of sot alol on the QT dispersion in patients with atrioventricular accessory pathways u nderwent radiofrequency catheter ablation (RFCA). Methods: Thirt y-six patients were divided into 2 groups by random. One was the drug group(18 cases) treated by RFCA， and sotalol 160 mg was orally administered and intracar diac electrophysiological study was performed every 30 min for 5 times. Th e other group(control group, 18 cases) only treated by RFCA.QTd,QTcd and QTLcd w ere measured before and after RFCA. Results: There was no signif icant difference with QT dispersion before and after RFCA in control group. When compared with before RFCA, QTd in patients administered sotalol was (30.9 ±14.3) ms vs (24.7±9.6) ms; QTcd(33.7±17.1) ms vs (25.2±10.1) ms; QT Lcd(30.8±14.1)ms vs (25.6±19.4) ms (P<0.05). Conclusion: Sotalol can slightly lower QT dispersion, which is beneficial for preventing malignant ventricular arrthythmia. It is safe in RFCA in pateints with accessory pathway.
